Compounds > almotriptan
Page last updated: 2024-09-03

almotriptan and chloramphenicol

almotriptan has been researched along with chloramphenicol in 5 studies

Compound Research Comparison

Studies
(almotriptan)		Trials
(almotriptan)		Recent Studies (post-2010)
(almotriptan)		Studies
(chloramphenicol)		Trials
(chloramphenicol)		Recent Studies (post-2010) (chloramphenicol)
188594220,1133881,464

Protein Interaction Comparison

ProteinTaxonomyalmotriptan (IC50)chloramphenicol (IC50)
30S ribosomal protein S6Escherichia coli K-120.43
30S ribosomal protein S7Escherichia coli K-120.43
50S ribosomal protein L15Escherichia coli K-120.43
50S ribosomal protein L10Escherichia coli K-120.43
50S ribosomal protein L11Escherichia coli K-120.43
50S ribosomal protein L7/L12Escherichia coli K-120.43
50S ribosomal protein L19Escherichia coli K-120.43
50S ribosomal protein L1Escherichia coli K-120.43
50S ribosomal protein L20Escherichia coli K-120.43
50S ribosomal protein L27Escherichia coli K-120.43
50S ribosomal protein L28Escherichia coli K-120.43
50S ribosomal protein L29Escherichia coli K-120.43
50S ribosomal protein L31Escherichia coli K-120.43
50S ribosomal protein L31 type BEscherichia coli K-120.43
50S ribosomal protein L32Escherichia coli K-120.43
50S ribosomal protein L33Escherichia coli K-120.43
50S ribosomal protein L34Escherichia coli K-120.43
50S ribosomal protein L35Escherichia coli K-120.43
50S ribosomal protein L36Escherichia coli K-120.43
30S ribosomal protein S10Escherichia coli K-120.43
30S ribosomal protein S11Escherichia coli K-120.43
30S ribosomal protein S12Escherichia coli K-120.43
30S ribosomal protein S13Escherichia coli K-120.43
30S ribosomal protein S16Escherichia coli K-120.43
30S ribosomal protein S18Escherichia coli K-120.43
30S ribosomal protein S19Escherichia coli K-120.43
30S ribosomal protein S20Escherichia coli K-120.43
30S ribosomal protein S2Escherichia coli K-120.43
30S ribosomal protein S3Escherichia coli K-120.43
30S ribosomal protein S4Escherichia coli K-120.43
30S ribosomal protein S5Escherichia coli K-120.43
30S ribosomal protein S8Escherichia coli K-120.43
30S ribosomal protein S9Escherichia coli K-120.43
50S ribosomal protein L13Escherichia coli K-120.43
50S ribosomal protein L14Escherichia coli K-120.43
50S ribosomal protein L16Escherichia coli K-120.43
50S ribosomal protein L23Escherichia coli K-120.43
30S ribosomal protein S15Escherichia coli K-120.43
50S ribosomal protein L17Escherichia coli K-120.43
50S ribosomal protein L21Escherichia coli K-120.43
50S ribosomal protein L30Escherichia coli K-120.43
50S ribosomal protein L6Escherichia coli K-120.43
30S ribosomal protein S14Escherichia coli K-120.43
30S ribosomal protein S17Escherichia coli K-120.43
30S ribosomal protein S1Escherichia coli K-120.43
50S ribosomal protein L18Escherichia coli K-120.43
50S ribosomal protein L2Escherichia coli K-120.43
50S ribosomal protein L3Escherichia coli K-120.43
50S ribosomal protein L24Escherichia coli K-120.43
50S ribosomal protein L4Escherichia coli K-120.43
50S ribosomal protein L22Escherichia coli K-120.43
50S ribosomal protein L5Escherichia coli K-120.43
30S ribosomal protein S21Escherichia coli K-120.43
50S ribosomal protein L25Escherichia coli K-120.43
50S ribosomal protein L36 2Escherichia coli K-120.43

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for almotriptan and chloramphenicol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for almotriptan and chloramphenicol

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011